Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.

Lipman PD, Loudon K, Dluzak L, Moloney R, Messner D, Stoney CM.

Trials. 2017 Nov 10;18(1):532. doi: 10.1186/s13063-017-2267-y.

2.

Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.

Forbes G, Loudon K, Treweek S, Taylor SJC, Eldridge S.

J Clin Epidemiol. 2017 Oct;90:119-126. doi: 10.1016/j.jclinepi.2017.06.007. Epub 2017 Jun 17.

PMID:
28629699
3.

The PRECIS-2 tool has good interrater reliability and modest discriminant validity.

Loudon K, Zwarenstein M, Sullivan FM, Donnan PT, Gágyor I, Hobbelen HJSM, Althabe F, Krishnan JA, Treweek S.

J Clin Epidemiol. 2017 Aug;88:113-121. doi: 10.1016/j.jclinepi.2017.06.001. Epub 2017 Jun 8.

PMID:
28603007
4.

PRECIS-2 helps researchers design more applicable RCTs while CONSORT Extension for Pragmatic Trials helps knowledge users decide whether to apply them.

Zwarenstein M, Treweek S, Loudon K.

J Clin Epidemiol. 2017 Apr;84:27-29. doi: 10.1016/j.jclinepi.2016.10.010. Epub 2017 Jan 28. No abstract available.

PMID:
28137671
5.

What do patients and the public know about clinical practice guidelines and what do they want from them? A qualitative study.

Fearns N, Kelly J, Callaghan M, Graham K, Loudon K, Harbour R, Santesso N, McFarlane E, Thornton J, Treweek S.

BMC Health Serv Res. 2016 Feb 24;16:74. doi: 10.1186/s12913-016-1319-4.

6.

Patients, health information, and guidelines: A focus-group study.

Liira H, Saarelma O, Callaghan M, Harbour R, Jousimaa J, Kunnamo I, Loudon K, Mcfarlane E, Treweek S.

Scand J Prim Health Care. 2015;33(3):212-9. doi: 10.3109/02813432.2015.1067517. Epub 2015 Jul 24.

7.

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

Treweek S, Altman DG, Bower P, Campbell M, Chalmers I, Cotton S, Craig P, Crosby D, Davidson P, Devane D, Duley L, Dunn J, Elbourne D, Farrell B, Gamble C, Gillies K, Hood K, Lang T, Littleford R, Loudon K, McDonald A, McPherson G, Nelson A, Norrie J, Ramsay C, Sandercock P, Shanahan DR, Summerskill W, Sydes M, Williamson P, Clarke M.

Trials. 2015 Jun 5;16:261. doi: 10.1186/s13063-015-0776-0.

8.

The PRECIS-2 tool: designing trials that are fit for purpose.

Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M.

BMJ. 2015 May 8;350:h2147. doi: 10.1136/bmj.h2147. No abstract available.

PMID:
25956159
9.

Patient and public attitudes to and awareness of clinical practice guidelines: a systematic review with thematic and narrative syntheses.

Loudon K, Santesso N, Callaghan M, Thornton J, Harbour J, Graham K, Harbour R, Kunnamo I, Liira H, McFarlane E, Ritchie K, Treweek S.

BMC Health Serv Res. 2014 Jul 27;14:321. doi: 10.1186/1472-6963-14-321. Review.

10.

Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.

Loudon K, Zwarenstein M, Sullivan F, Donnan P, Treweek S.

Trials. 2013 Apr 27;14:115. doi: 10.1186/1745-6215-14-115.

11.

Incomplete reporting of recruitment information in breast cancer trials published between 2003 and 2008.

Treweek S, Loudon K.

J Clin Epidemiol. 2011 Nov;64(11):1216-22. doi: 10.1016/j.jclinepi.2011.01.007. Epub 2011 Apr 23. Review.

PMID:
21524567
12.
13.

Publication bias in clinical trials due to statistical significance or direction of trial results.

Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K.

Cochrane Database Syst Rev. 2009 Jan 21;(1):MR000006. doi: 10.1002/14651858.MR000006.pub3. Review.

PMID:
19160345

Supplemental Content

Loading ...
Support Center